Osteoprotegerin and breast cancer risk by hormone receptor subtype: a nested case-control study in the EPIC cohort

BACKGROUND: Circulating osteoprotegerin (OPG), a member of the receptor activator of nuclear factor kappa-B (RANK) axis, may influence breast cancer risk via its role as the decoy receptor for both the RANK ligand (RANKL) and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). Circulati...

Descripción completa

Detalles Bibliográficos
Autores principales: Fortner, Renée T., Sarink, Danja, Schock, Helena, Johnson, Theron, Tjønneland, Anne, Olsen, Anja, Overvad, Kim, Affret, Aurélie, His, Mathilde, Boutron-Ruault, Marie-Christine, Boeing, Heiner, Trichopoulou, Antonia, Naska, Androniki, Orfanos, Philippos, Palli, Domenico, Sieri, Sabina, Mattiello, Amalia, Tumino, Rosario, Ricceri, Fulvio, Bueno-de-Mesquita, H. Bas, Peeters, Petra H. M., Van Gils, Carla H., Weiderpass, Elisabete, Lund, Eiliv, Quirós, J. Ramón, Agudo, Antonio, Sánchez, Maria-José, Chirlaque, María-Dolores, Ardanaz, Eva, Dorronsoro, Miren, Key, Tim, Khaw, Kay-Tee, Rinaldi, Sabina, Dossus, Laure, Gunter, Marc, Merritt, Melissa A., Riboli, Elio, Kaaks, Rudolf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5297136/
https://www.ncbi.nlm.nih.gov/pubmed/28173834
http://dx.doi.org/10.1186/s12916-017-0786-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5297136/
https://www.ncbi.nlm.nih.gov/pubmed/28173834
http://dx.doi.org/10.1186/s12916-017-0786-8

Ejemplares similares